Results 121 to 130 of about 39,253,262 (150)
Some of the next articles are maybe not open access.

[Behavioral and neurochemical aspects of the antidepressive action of GSB-106 dipeptide BDNF fragment].

Eksperimental'naia i klinicheskaia farmakologiia, 2013
The behavioral and neurochemical effects of synthetic dipeptide fragment GSB-106 of BDNF, administered in a single dose of 0.1 mg/kg (i.p.), have been studied in comparison to amitriptyline (10 mg/kg, i.p.) on the Nomura depressive state model employing forced-rotating-wheel swim test (FST) in Wistar rats.
V S, Kudrin   +6 more
openaire   +1 more source

Capillary electrophoresis method for simultaneous determination of neuropeptide GSB-106 and hyaluronan in the preparation of a nasal formulation

Industrial laboratory. Diagnostics of materials
Capillary electrophoresis, using capillary electrokinetic chromatography, was used for the simultaneous quantitative determination of the dipeptide GSB-106 and sodium hyaluronan with a molecular weight of 130 kDa in a dosage form developed for intranasal delivery of the peptide to the central nervous system. An optimized leading electrolyte composition
M. M. Antonova   +5 more
openaire   +1 more source

The effect of the BDNF mimetic GSB-106 on behavior and inflammation levels in Wistar rats with experimental autism spectrum disorder

Vestnik Moskovskogo universiteta Seria 16 Biologia
Autism spectrum disorder (ASD) is a heterogeneous group of neurodevelopmental disorders characterized by defi cits in social interaction, stereotypic behavior, and restricted interests. In ASD, dysregulation of proteins associated with synaptic plasticity, particularly brain-derived neurotrophic factor (BDNF), as well as elevated levels of infl ...
E.V. E.V.   +3 more
openaire   +1 more source

NOOTROPICACTIVITY OF BRAIN-DERIVED NEUROTROPHIC FACTOR DIPEPTIDE MIMETIC GSB-106

Problems Of Biological, Medical And Pharmaceutical Chemistry, 2020
P.Yu. Povarnina   +4 more
openaire   +1 more source

[Study of structure-activity relationship in series of Gsb-106 analogues-dipeptide mimetics of brain-derived neurotrophic factor].

Bioorganicheskaia khimiia, 2015
In previous work we have obtained a dimeric dipeptide mimetic of 4th loop of BDNF - hexamethylenediamide bis-(N-monosuccinil-L-seryl-L-lysine) (GSB-106), having a neuroprotective activity in vitro in a concentration range 10(-5)-10(-8) M and an antidepressant activity in vivo at doses 0.1 and 1 mg/kg i.p. in rats.
A V, Tarasiuk   +8 more
openaire   +1 more source

SYNTHESIS OF THE PHARMACOLOGICALLY ACTIVE ANALOG OF THE GSB-106, DIPEPTID MIMETIC OF BDNF

Problems Of Biological, Medical And Pharmaceutical Chemistry, 2019
N.M. Sazonova   +9 more
openaire   +1 more source

Dipeptide BDNF mimetic GSB-106 prevents depression-like behavior and cognitive impairment caused by ischemic stroke in rats

Problems of Biological Medical and Pharmaceutical Chemistry, 2022
P.Yu. Povarnina   +3 more
openaire   +1 more source

P.1.019 Neuroprotective properties of a low molecular weight dipeptide analogue of BDNF -GSB-106 in cell culture

European Neuropsychopharmacology, 2011
I.O. Logvinov   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy